{"transactions":[{"id":1361550,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-18T16:05:50.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":46153,"price":3.25,"value":149997.25,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":297941,"source":{"system":"sec-edgar","filing":"0001062993-24-019265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324019265/form4.xml","form_type":"4"}},{"id":1401473,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":170475,"price":0.125,"value":21309.375,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":170475,"derivative":{"exercise_price":5.636,"exercise_date":"2024-09-18","expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":170475},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401472,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":35715,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":35715},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401471,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":9768,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2023-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":9768},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401470,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":29557,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":29557},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401469,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":38610,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":38610},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401468,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":35715,"price":5.636,"value":201289.74,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":251788,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401467,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":9768,"price":5.636,"value":55052.448,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":216073,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401466,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":29557,"price":5.636,"value":166583.252,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":206305,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401465,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":38610,"price":5.636,"value":217605.96,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":176748,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1556035,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-04-01T20:54:14.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":38610,"price":7.77,"value":299999.7,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":38610,"derivative":{"exercise_price":7.64,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":38610},"source":{"system":"sec-edgar","filing":"0001062993-24-007661","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324007661/form4.xml","form_type":"4"}},{"id":1556034,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:54:14.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":38610,"price":7.77,"value":299999.7,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":138138,"source":{"system":"sec-edgar","filing":"0001062993-24-007661","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324007661/form4.xml","form_type":"4"}},{"id":1651374,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-02-09T16:34:03.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":413793,"price":0.725,"value":299999.925,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":413793,"derivative":{"exercise_price":1,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":413793},"source":{"system":"sec-edgar","filing":"0001062993-24-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324002770/form4.xml","form_type":"4"}},{"id":1651373,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T16:34:03.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":413793,"price":0.725,"value":299999.925,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1393392,"source":{"system":"sec-edgar","filing":"0001062993-24-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324002770/form4.xml","form_type":"4"}},{"id":1749498,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-11-03T16:29:52.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":136752,"price":0.125,"value":17094.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":136752,"derivative":{"exercise_price":2.34,"exercise_date":"2023-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":136752},"source":{"system":"sec-edgar","filing":"0001062993-23-020103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323020103/form4.xml","form_type":"4"}},{"id":1764280,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1,"value":500000.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":500000,"derivative":{"exercise_price":1,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764279,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.973,"value":4865.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9501 to $0.9898, inclusive. Mr. Zauderer undertakes to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":22116,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764278,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.93,"value":4650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9265 to $0.9399, inclusive. Mr. Zauderer undertakes to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17116,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764277,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1,"value":500000.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":979599,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":3590255,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T17:59:18.000Z","date":"2019-03-15","kind":"purchase","acquired":true,"shares":1000,"price":3.96,"value":3960.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4790469,"source":{"system":"sec-edgar","filing":"0000891839-19-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000089183919000042/edgar.xml","form_type":"4/A","original_submission_date":"2019-03-18"}},{"id":3590254,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T17:59:18.000Z","date":"2019-03-14","kind":"purchase","acquired":true,"shares":1000,"price":4,"value":4000.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4789469,"source":{"system":"sec-edgar","filing":"0000891839-19-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000089183919000042/edgar.xml","form_type":"4/A","original_submission_date":"2019-03-18"}},{"id":3590251,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T16:30:54.000Z","date":"2019-03-15","kind":"purchase","acquired":true,"shares":1000,"price":3.96,"value":3960.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4790469,"source":{"system":"sec-edgar","filing":"0000891839-19-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000089183919000038/edgar.xml","form_type":"4"}},{"id":3590250,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":78320,"kind":"person","name":"FRIEDBERG ALBERT","position":1,"cik":"0001268239","reported_name":"FRIEDBERG ALBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T16:30:54.000Z","date":"2019-03-14","kind":"purchase","acquired":true,"shares":1000,"price":4,"value":4000.0,"ownership":{"direct":false,"nature":"By FCMI Parent Co."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4789469,"source":{"system":"sec-edgar","filing":"0000891839-19-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1268239/000089183919000038/edgar.xml","form_type":"4"}},{"id":3843148,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":8157067,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":815698},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843147,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":581577,"ownership":{"direct":false,"nature":"By Jordan M. Zauderer Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":95448},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843146,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":581577,"ownership":{"direct":false,"nature":"By Jeremy C. Zauderer Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":95448},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843145,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":569993,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":93547},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843144,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":815698,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":815698,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843143,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":95448,"ownership":{"direct":false,"nature":"By Jordan M. Zauderer Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":212161,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843142,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":95448,"ownership":{"direct":false,"nature":"By Jeremy C. Zauderer Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":213209,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843141,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":93547,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":177748,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}}]}